Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "Kawasaki disease":

Management of Kawasaki disease in adults. Denby KJ et al. Heart. (2017)

Kawasaki disease. Sundel RP et al. Rheum Dis Clin North Am. (2015)

Kawasaki disease: State of the art. Newburger JW et al. Congenit Heart Dis. (2017)

Search results

Items: 1 to 20 of 5527

1.

[National consensus on the diagnosis, cardiological treatment, and follow-up of Kawasaki disease].

Higelmo Gómez H, Gómez González B, Valverde Pérez N, González García J.

An Pediatr (Barc). 2018 Dec 11. pii: S1695-4033(18)30529-0. doi: 10.1016/j.anpedi.2018.11.006. [Epub ahead of print] Spanish. No abstract available.

2.

Augmented ILT3/LILRB4 Expression of Peripheral Blood Antibody Secreting Cells in the Acute-Phase of Kawasaki Disease.

Sugahara-Tobinai A, Inui M, Metoki T, Watanabe Y, Onuma R, Takai T, Kumaki S.

Pediatr Infect Dis J. 2018 Dec 13. doi: 10.1097/INF.0000000000002259. [Epub ahead of print]

PMID:
30550513
3.

Kawasaki disease-related arthritis with synovial involvement.

Ito T, Hoshina T, Taku K, Kusuhara K.

Pediatr Int. 2018 Dec 11. doi: 10.1111/ped.13721. [Epub ahead of print] No abstract available.

PMID:
30548392
4.

A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.

Noto T, Seto H, Fukuhara J, Murabayashi M, Yachie A, Ayusawa M, Morioka I.

BMC Pediatr. 2018 Dec 12;18(1):386. doi: 10.1186/s12887-018-1365-7.

5.

A new scoring system to predict Kawasaki disease with coronary artery lesions.

Hua W, Ma F, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.

Clin Rheumatol. 2018 Dec 6. doi: 10.1007/s10067-018-4393-7. [Epub ahead of print]

PMID:
30523553
6.

HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.

Ahn JG, Bae Y, Shin D, Nam J, Kim KY, Kim DS.

Rheumatology (Oxford). 2018 Dec 7. doi: 10.1093/rheumatology/key356. [Epub ahead of print]

PMID:
30535242
7.

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative.

de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Brogan P, Beresford MW.

Rheumatology (Oxford). 2018 Dec 7. doi: 10.1093/rheumatology/key344. [Epub ahead of print]

PMID:
30535127
8.

Introduction, epidemiology and classification of vasculitis.

Watts RA, Robson J.

Best Pract Res Clin Rheumatol. 2018 Feb;32(1):3-20. doi: 10.1016/j.berh.2018.10.003. Epub 2018 Nov 16. Review.

PMID:
30526896
9.

Transient Q-waves in an infant with asymptomatic myocardial infarction due to Kawasaki disease.

Akagawa D, Motoki N, Hachiya A, Akazawa Y.

Cardiol Young. 2018 Dec 6:1-4. doi: 10.1017/S1047951118001919. [Epub ahead of print]

PMID:
30520707
10.

A novel model for predicting non-responsiveness to intravenous immunoglobulins in Kawasaki disease: The Singapore experience.

Grignani R, Rajgor DD, Leow YG, Heng CK, Quek SC.

J Paediatr Child Health. 2018 Dec 5. doi: 10.1111/jpc.14329. [Epub ahead of print]

PMID:
30520192
11.

Spatiotemporal clustering of cases of Kawasaki disease and associated coronary artery aneurysms in Canada.

Hearn J, McCrindle BW, Mueller B, O'Shea S, Bernknopf B, Labelle M, Manlhiot C.

Sci Rep. 2018 Dec 5;8(1):17682. doi: 10.1038/s41598-018-35848-9.

12.

Gene expression in Kawasaki disease.

Isaacs D.

J Paediatr Child Health. 2018 Dec;54(12):1400-1401. doi: 10.1111/jpc.14258. No abstract available.

PMID:
30506788
13.

Atypical coronary artery aneurysms due to Kawasaki disease in Noonan syndrome with a novel PTPN11 mutation.

Takai S, Takasawa K, Doi S.

Cardiol Young. 2018 Dec 4:1-3. doi: 10.1017/S1047951118001877. [Epub ahead of print]

PMID:
30511597
14.

Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.

Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.

Eur J Pediatr. 2018 Nov 29. doi: 10.1007/s00431-018-3297-5. [Epub ahead of print]

PMID:
30499051
15.

Conditions and Factors Associated With Spontaneous Coronary Artery Dissection (from a National Population-Based Cohort Study).

Krittanawong C, Kumar A, Johnson KW, Luo Y, Yue B, Wang Z, Bhatt DL.

Am J Cardiol. 2018 Oct 30. pii: S0002-9149(18)31967-2. doi: 10.1016/j.amjcard.2018.10.012. [Epub ahead of print]

PMID:
30477805
16.

[Clinical features of children with Kawasaki disease aged over 5 years].

Tian F, Zhang J, Xiao L.

Zhongguo Dang Dai Er Ke Za Zhi. 2018 Nov;20(11):917-920. Chinese.

17.

Macropolycyte in Pediatrics.

Lee AC.

J Pediatr Hematol Oncol. 2018 Nov 20. doi: 10.1097/MPH.0000000000001344. [Epub ahead of print]

PMID:
30475299
18.

Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals.

Goswami N, Marzan K, De Oliveira E, Wagner-Lees S, Szmuszkovicz J.

Children (Basel). 2018 Nov 21;5(11). pii: E155. doi: 10.3390/children5110155.

19.

Early childhood exposure to maternal smoking and Kawasaki Disease: A longitudinal survey in Japan.

Yorifuji T, Tsukahara H, Doi H.

Sci Total Environ. 2018 Nov 14;655:141-146. doi: 10.1016/j.scitotenv.2018.11.194. [Epub ahead of print]

PMID:
30469059
20.

New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity.

Yoo BW.

Korean Circ J. 2018 Nov 13. doi: 10.4070/kcj.2018.0365. [Epub ahead of print] No abstract available.

Supplemental Content

Loading ...
Support Center